Short Summary
Essar Gujarat Ltd. imported a second-hand plant from West Germany to produce Sponge Iron. The Collector of Customs sought to enhance the declared transaction value by including various payments made to collaborators and patent holders, such as Midrex International for process rights. Essar challenged this addition before the Tribunal.
Detailed Summary
For any business looking to manufacture a new product, importing the right machinery is only half the battle; surviving the customs valuation process is the other half. When a company pays for both the physical equipment and the intellectual property needed to run
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Customs, Excise and Gold Tribunal - Delhi. Understanding the court's reasoning in Essar Gujarat Ltd. vs Collector Of Customs (Preventive) is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Chugai Seiyaku Kabushiki Kaisha & Anr.vsNatco Pharma Limited
Plaintiffs (Chugai Seiyaku Kabushiki Kaisha & Anr.) filed a suit seeking permanent injunction against Natco Pharma Limited for infringing Indian Patent No. 294424, which covers the tetracyclic compound Alectinib (Alecensa®). The dispute centered on the Defendant's alleged export and potential commercial launch of generic Alectinib products. The matter was amicably resolved.
Indian Vacuum Brake Co., Ltd.vsE.S. Luard
The petitioner challenged the validity of Patent No. 8018, granted to E.S. Luard, arguing that it lacked novelty and invention, and was anticipated by prior art (Hardy's Patent and existing designs). The court found that the respondent's patent was not an improvement on the petitioner's design and disclosed no invention.
Republic Technologies (Na) LlcvsVipin Pathak Trading As M/S Pathak Impex
The Delhi High Court addressed a suit filed by Republic Technologies against Vipin Pathak regarding the alleged infringement of the 'OCB' trademark and copyright related to smoking accessories. While the court noted that the defendant acknowledged the plaintiff's rights, it also accepted the defendant's willingness to change their logo and mark. Consequently, an existing interim order was made absolute, while the matter was scheduled for further hearing after the defendant presented proposed changes.
Fmc Corporation & Anr.vsNatco Pharma Limited
The plaintiffs filed a commercial suit alleging infringement by Natco Pharma Limited of their Indian Patents IN 201307 and IN 213332, covering the molecule Chlorantraniliprole (CTPR). The defendant challenged the plaint through various applications. This order addressed these interim applications.
Eris Lifesciences LimitedvsController Of Patents & Anr.
Eris Lifesciences Limited filed a revocation petition challenging Patent No. IN 243301, arguing that it should be revoked because the claims were covered by an earlier genus patent (IN 227719). The Delhi High Court noted that another appeal concerning the same patent was already pending before the court. Consequently, the court directed both parties to serve notices upon each other and listed the matter together with the existing appeal for a hearing on April 6, 2022.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.